Fdc
Live Price
Recent news and updates for FDC will appear here soon.
"Robust technical setup for FDC with strong AI conviction. The bullish trend in the healthcare space is accelerating while RSI at 48 suggests there is still significant room for upside before reaching overbought territory."
Verified by Stockmo Intelligence Grid
Citing cross-referenced internal documents and market technicals
FDC Limited, together with its subsidiaries, manufactures and trades in pharmaceutical products in India, the United States, and internationally. The company offers pharmaceutical formulations for various therapeutic segments, including anti-infectives, gastrointestinal, ophthalmology, vitamins, minerals, dietary supplements, cardiovascular and anti-diabetic therapies, respiratory care, gynaecology, dermatology, and analgesics in the form of tablets, capsules, oral liquids, ophthalmic drops, topical preparations, and paediatric-friendly solutions. It also provides functional food, such as flavoured ORS powders, ready-to-drink electrolyte beverages, vitamin-enriched supplements, antioxidant blends and protein-fortified drinks; and various active pharmaceutical ingredients. The company sells its products under the Zifi, Zefu, Zocon, Amodep-AT, Zathrin, Vitcofol, Ziglim, Ziglim-M,Mycoderm, Zoxan, Cotaryl, Pyrimon DF, Zipod, Electral, and Enerzal brands. It also exports its products to approximately 50 countries. FDC Limited was founded in 1936 and is based in Mumbai, India.
As of the latest market session, Fdc (FDC) is trading at ₹409.8, representing a move of 0.58% from the previous close.
Fdc is listed and traded under the ticker symbol FDC on the National Stock Exchange of India (NSE) and Bombay Stock Exchange (BSE).
Today, Fdc's stock price moved by 0.58%. Long-term growth trends depend on company financials, technical moving averages, and sector momentum in the Healthcare industry.
Our proprietary AI Momentum engine calculates a 90% bullish probability for FDC stock over the next 3-5 days. View the live interactive chart on Stockmo to see dynamic technical forecasting.
Over the past 52 weeks, Fdc shares reached a high of ₹527.8 and hit a low of ₹312.95.
FDC exhibits standard volatility for a Healthcare stock, with an average daily trading volume of 1,37,556 shares. Detailed technical beta indicators are available on the Stockmo charting engine.
Fdc has a market capitalization of ₹6675.21 Cr, designating its size class inside the Healthcare sector.
Fdc has a current dividend yield of 244.00%. Companies may adjust payout ratios depending on quarterly earnings growth and reinvestment opportunities.
Fdc's trailing Price-to-Earnings (P/E) ratio is 23.71. This indicates how much investors are willing to pay for every rupee of the company's annual net earnings.
You can purchase Fdc (FDC) shares through any SEBI-registered stockbroker (such as Kite/Zerodha, Groww, or Angel One) by funding your trading account and executing a buy order on the NSE or BSE.
Fdc's financial health, solvency, growth, and quality metrics are tracked using our proprietary Multibagger V2 score. You can explore FDC's detailed 5-tier financial scorecard and compare it with market competitors on the Stockmo Multibagger Screener page.
Institutional order blocks and pristine support/resistance triggers for FDC are monitored in real-time. View live technical entry levels, stop loss bounds, and target prices on our interactive Supply & Demand Trading Engine or scan entire market segments using the Basket Scanner.
Fdc operates inside the Healthcare sector. You can analyze sector-wide trends, relative strengths, and locate top emerging leaders in this space using our Sector Analysis Hub.